Drugs / Ezetemibe
last change Jun 2023 re-read 2 minutes ago

Ezetemibe

Developed for
atherosclerotic cardiovascular disease · hyperlipidemia
Investigated by
Yonsei University

Trials 1 · a red edge is where a trial was stopped

2024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT05705804 Jun 2023 → May 2027 expected atherosclerotic cardiovascular disease, hyperlipidemia Yonsei University Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ezetemibe ClinicalTrials.gov intervention name — accepted as the source's own label NCT05705804